Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AP3M1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR7110 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDLBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TACC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASMTL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Homologene neighbors
ANAPC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MRPL20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XRCC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ECH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPCD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on